Document Detail

Improving patient compliance with hypertension treatment: mission possible?
MedLine Citation:
PMID:  20626345     Owner:  NLM     Status:  In-Process    
Hypertension, the leading cause of mortality and the third largest cause of disability, is poorly controlled worldwide. The failure to control hypertension takes an unacceptable toll on patients and their families. In addition to the personal cost, to the individual patient, uncontrolled hypertension creates huge, avoidable economic burdens when viewed in terms of the general population. Almost one-half of patients drop out entirely from treatment within 1 year. This review summarizes key challenges related to hypertension management with special focus on patient compliance. Firstly, we will present consequences of poor blood pressure control. Secondly, methods of patient compliance assessment will be reviewed. Thirdly, we will present recent studies assessing adherence with hypertension treatment. Finally, we will review potential solutions to improve patient compliance and blood pressure control which are of crucial importance for reduction of hypertension-related morbidity and mortality.
Marzena Chrostowska; Krzysztof Narkiewicz
Related Documents :
19584385 - Clevidipine: an ultra short-acting calcium channel antagonist for acute hypertension.
9570425 - Potential cardioprotective effect of mibefradil in the long-term treatment of hypertens...
3241335 - Effects of monotherapy and withdrawal of antihypertensive drugs in the treatment of hyp...
19702525 - Acute severe arterial hypertension: therapeutic options.
8781755 - Prevalence of hypertension and rate of blood pressure control as assessed by home blood...
1437035 - Blood pressure response to routine restorative dental treatment with and without local ...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Current vascular pharmacology     Volume:  8     ISSN:  1875-6212     ISO Abbreviation:  Curr Vasc Pharmacol     Publication Date:  2010 Nov 
Date Detail:
Created Date:  2010-09-15     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101157208     Medline TA:  Curr Vasc Pharmacol     Country:  United Arab Emirates    
Other Details:
Languages:  eng     Pagination:  804-7     Citation Subset:  IM    
Department of Hypertension and Diabetology, Medical University of Gdansk, Gdansk, Poland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The effect of antihypertensive agents on insulin sensitivity, lipids and haemostasis.
Next Document:  Why and how we should treat elderly patients with hypertension?